|This article needs additional citations for verification. (April 2014)|
|Defunct||14 October 2013|
|Headquarters||Huntingdon, United Kingdom|
Phytopharm is a pharmaceutical company based in the United Kingdom. According to the company's website, Phytopharm's lead products are Cogane and Myogane, which are members of the sapogenin class of compounds. It is listed on the London Stock Exchange and is a constituent of the FTSE Fledgling Index.
Company collapsed following failure of its main drug during clinical trials.
- "Phytopharm shareholders approve IXICO acquisition". 14 October 2013. Retrieved 9 December 2014.
- "Phytopharm says Cogane Phase II trials disappoint". 18 February 2013. Retrieved 9 December 2014.
|This article about a company of the UK is a stub. You can help Wikipedia by expanding it.|